Core Laboratories N.V.
CLBNYSEEnergy● Active
$13.43
+$0.50(+3.87%)
Market Cap$619078439
P/E Ratio—
52W High$20.36
52W Low$9.72
Core Laboratories N.V. (CLB) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CLB · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
$0.06
Est. $0.06 · +0.0%
Revenue
$0.12B
Est. $0.12B · -1.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
🔥 4-Quarter EPS Beat Streak
CLB reports quarterly as a NYSE-listed Oil & Gas Equipment & Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | $0.08 | — | — | — | $0.13B | — |
| — Q2 FY2026 | Apr 29, 2026 | $0.06 | $0.06 | +0.0% | $0.12B | $0.12B | -1.0% |
| ▲ Q1 FY2026 | Feb 4, 2026 | $0.19 | $0.21 | +9.8% | $0.14B | $0.13B | +4.6% |
| ▲ Q4 FY2025 | Oct 22, 2025 | $0.19 | $0.22 | +15.8% | $0.13B | $0.13B | +4.6% |
| ▲ Q3 FY2025 | Jul 23, 2025 | $0.18 | $0.19 | +5.6% | $0.13B | $0.13B | -0.6% |
| ▼ Q2 FY2025 | Apr 23, 2025 | $0.15 | $0.14 | -6.7% | $0.12B | $0.13B | -4.2% |
| ▼ Q1 FY2025 | Jan 29, 2025 | $0.23 | $0.22 | -4.3% | $0.13B | $0.13B | +3.3% |
| ▲ Q4 FY2024 | Oct 23, 2024 | $0.23 | $0.25 | +8.7% | $0.13B | $0.13B | +0.3% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
$0.08
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026
EPS Actual
$0.06
EPS Est.
$0.06
EPS Surpr.
+0.0%
Revenue
$0.12B
Q1 FY2026
Feb 4, 2026Beat
EPS Actual
$0.21
EPS Est.
$0.19
EPS Surpr.
+9.8%
Revenue
$0.14B
Q4 FY2025
Oct 22, 2025Beat
EPS Actual
$0.22
EPS Est.
$0.19
EPS Surpr.
+15.8%
Revenue
$0.13B
Q3 FY2025
Jul 23, 2025Beat
EPS Actual
$0.19
EPS Est.
$0.18
EPS Surpr.
+5.6%
Revenue
$0.13B
Q2 FY2025
Apr 23, 2025Miss
EPS Actual
$0.14
EPS Est.
$0.15
EPS Surpr.
-6.7%
Revenue
$0.12B
Q1 FY2025
Jan 29, 2025Miss
EPS Actual
$0.22
EPS Est.
$0.23
EPS Surpr.
-4.3%
Revenue
$0.13B
Q4 FY2024
Oct 23, 2024Beat
EPS Actual
$0.25
EPS Est.
$0.23
EPS Surpr.
+8.7%
Revenue
$0.13B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.23 | $0.23 | $0.23 | 1 |
| Q3 FY2027 | $0.25 | $0.25 | $0.25 | 1 |
| Q2 FY2027 | $0.23 | $0.23 | $0.23 | 1 |
| Q1 FY2027 | $0.13 | $0.13 | $0.13 | 1 |
| Q4 FY2026 | $0.20 | $0.20 | $0.20 | 1 |
| Q3 FY2026 | $0.19 | $0.19 | $0.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 29, 2026 | +0.0% | $16.77 | $17.30 | +3.16% |
| ▲ Q1 FY2026 | Feb 4, 2026 | +9.8% | $19.64 | $19.61 | -0.15% |
| ▲ Q4 FY2025 | Oct 22, 2025 | +15.8% | $12.04 | $12.77 | +6.06% |
| ▲ Q3 FY2025 | Jul 23, 2025 | +5.6% | $11.77 | $12.62 | +7.22% |
| ▼ Q2 FY2025 | Apr 23, 2025 | -6.7% | $12.44 | $12.07 | -2.97% |
| ▼ Q1 FY2025 | Jan 29, 2025 | -4.3% | $18.53 | $18.54 | +0.05% |
| ▲ Q4 FY2024 | Oct 23, 2024 | +8.7% | $17.25 | $17.08 | -0.99% |
| ▲ Q3 FY2024 | Jul 24, 2024 | +4.8% | $22.26 | $22.02 | -1.08% |
Q2 FY2026+3.16%
Report Date
Apr 29, 2026
EPS Beat/Miss
+0.0%
Price Before
$16.77
Price After
$17.30
Q1 FY2026-0.15%
Report Date
Feb 4, 2026
EPS Beat/Miss
+9.8%
Price Before
$19.64
Price After
$19.61
Q4 FY2025+6.06%
Report Date
Oct 22, 2025
EPS Beat/Miss
+15.8%
Price Before
$12.04
Price After
$12.77
Q3 FY2025+7.22%
Report Date
Jul 23, 2025
EPS Beat/Miss
+5.6%
Price Before
$11.77
Price After
$12.62
Q2 FY2025-2.97%
Report Date
Apr 23, 2025
EPS Beat/Miss
-6.7%
Price Before
$12.44
Price After
$12.07
Q1 FY2025+0.05%
Report Date
Jan 29, 2025
EPS Beat/Miss
-4.3%
Price Before
$18.53
Price After
$18.54
Q4 FY2024-0.99%
Report Date
Oct 23, 2024
EPS Beat/Miss
+8.7%
Price Before
$17.25
Price After
$17.08
Q3 FY2024-1.08%
Report Date
Jul 24, 2024
EPS Beat/Miss
+4.8%
Price Before
$22.26
Price After
$22.02
Avg Beat Reaction+2.37%
Avg Miss Reaction-1.46%
Beat Rate6 / 8 quarters
Largest Move+7.22% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CLB ends December
Core Laboratories N.V. (CLB) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $0.06 (in line with the analyst consensus of $0.06). CLB has beaten EPS estimates for 4 consecutive quarters. The next CLB earnings date is expected around September 1, 2026.
Each quarter, investors track CLB earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CLB revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CLB's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CLB earnings · 4 questionsCore Laboratories N.V.'s next earnings report is expected around September 1, 2026. CLB typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CLB historically reports after market close (AMC).
CLB earnings datewhen is CLB earningsCLB next earnings datewhen does CLB report earningsCLB earnings calendar
▸ Source: FMP · Core Laboratories N.V. SEC filings · US GAAP · Core Laboratories N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026